This points to the metabolic regulation of CML cell phenotype, namely the presence or absence of expressed BCR/Abl protein, as an important factor controlling the onset of TKi-resistant MRD and the related relapse of disease [4]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.